"Vaccinia virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.
| Descriptor ID |
D014616
|
| MeSH Number(s) |
B04.280.650.160.650.900
|
| Concept/Terms |
Rabbitpox virus- Rabbitpox virus
- Rabbitpox viruses
- Rabbit Pox Virus
- Rabbit Pox Viruses
Buffalopox virus- Buffalopox virus
- Buffalopox viruses
- virus, Buffalopox
- Buffalo Pox Virus
- Buffalo Pox Viruses
- Virus, Buffalo Pox
- Viruses, Buffalo Pox
|
Below are MeSH descriptors whose meaning is more general than "Vaccinia virus".
Below are MeSH descriptors whose meaning is more specific than "Vaccinia virus".
This graph shows the total number of publications written about "Vaccinia virus" by people in this website by year, and whether "Vaccinia virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 1 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccinia virus" by people in Profiles.
-
Grifoni A, Zhang Y, Tarke A, Sidney J, Rubiro P, Reina-Campos M, Filaci G, Dan JM, Scheuermann RH, Sette A. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T?cell responses in humans. Cell Host Microbe. 2022 12 14; 30(12):1662-1670.e4.
-
Schuelke MR, Wongthida P, Thompson J, Kottke T, Driscoll CB, Huff AL, Shim KG, Coffey M, Pulido J, Evgin L, Vile RG. Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity. J Immunother Cancer. 2019 07 17; 7(1):188.
-
Davies ML, Parekh NJ, Kaminsky LW, Soni C, Reider IE, Krouse TE, Fischer MA, van Rooijen N, Rahman ZSM, Norbury CC. A systemic macrophage response is required to contain a peripheral poxvirus infection. PLoS Pathog. 2017 Jun; 13(6):e1006435.
-
Sigal LJ. The Pathogenesis and Immunobiology of Mousepox. Adv Immunol. 2016; 129:251-76.
-
Fang M, Sigal LJ. Protective CD8+ T cell memory without help. Oncotarget. 2015 Oct 6; 6(30):28529-30.
-
Fang M, Remakus S, Roscoe F, Ma X, Sigal LJ. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization. J Virol. 2015 Jan; 89(1):776-83.
-
Guha R, Das S, Ghosh J, Naskar K, Mandala A, Sundar S, Dujardin JC, Roy S. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani. Vaccine. 2013 Apr 8; 31(15):1905-15.
-
Roscoe F, Xu RH, Sigal LJ. Characterization of ectromelia virus deficient in EVM036, the homolog of vaccinia virus F13L, and its application for rapid generation of recombinant viruses. J Virol. 2012 Dec; 86(24):13501-7.
-
Hersperger AR, Siciliano NA, Eisenlohr LC. Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity. J Virol. 2012 Jul; 86(13):7298-309.
-
Remakus S, Sigal LJ. Gamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response. J Virol. 2011 Dec; 85(23):12578-84.